News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Imricor Medical Systems.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Stocks: Polynovo leaps 12pc after coming out of trading halt, gets FDA approval
Health & Biotech
ASX Health Stocks: US patent another Prescient win for booming Aussie biotechs
Health & Biotech
ASX Health Stocks: Orthocell up 35pc after shaking on exclusive global patent deal
Health & Biotech
ASX Health Stocks: UK FSA welcomes Cann’s CBD capsules onto its approved list
Health & Biotech
ASX Health Stocks: Imugene levels up in Phase 1 trial, Imricor slides into Greece
News
Market Highlights and 5 ASX Small Caps to watch on Tuesday
Health & Biotech
ASX Health Stocks: OncoSil and Neuroscientific Biopharma release positive clinical results
Health & Biotech
Here are the ASX heart stocks fighting the number one killer disease in humans
Health & Biotech
ASX Health Stocks: Resapp gets TGA and CE mark approvals for its cough-counting app
Health & Biotech
ASX Health Stocks: Mach7 jumps 6.5pc on US sales, while large cap health companies slump
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
News
Market highlights and 5 ASX small caps to watch on Monday
News
Market highlights and ASX small caps to watch on Wednesday
News
Last Orders: What you might have missed on the ASX today
News
Rise and Shine: What you need to know before the ASX opens
News
Last Orders: What you might have missed on the ASX today
News